Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-11-21 Sale |
2024-11-25 4:05 pm |
Cyclerion Therapeutics Inc. | CYCN | Slate Path Capital LP Greenspan David Gerald 10% Owner |
357,880 | $1.5511 | $555,108 | 0 (Indirect) |
View |
| 2023-08-09 Sale |
2023-08-11 4:25 pm |
Cyclerion Therapeutics Inc. | CYCN | MCGUIRE TERRANCE Director |
8 | $3.395 | $27 | 37,010 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-25 Option Award |
2025-03-27 8:38 pm |
N/A N/A |
Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M Director 10% Owner |
181,818 | $2.75 | 559,275 (Direct) |
View |
| 2025-03-25 Option Award |
2025-03-27 4:20 pm |
N/A N/A |
Cyclerion Therapeutics Inc. | CYCN | Higgins Michael J Director |
9,090 | $2.75 | 30,740 (Direct) |
View |
| 2024-08-05 Option Award |
2024-08-07 4:05 pm |
N/A 2034-08-05 |
Cyclerion Therapeutics Inc. | CYCN | Graul Regina Margaret See Remarks |
55,849 | $0 | 55,849 (Direct) |
View |
Ownership |
2024-03-11 4:05 pm |
N/A N/A |
Cyclerion Therapeutics Inc. | CYCN | CHICKO RHONDA M. Chief Financial Officer |
0 | $0 | 18 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-26 4:07 pm |
N/A N/A |
Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M Director 10% Owner |
15,000 | $0 | 377,457 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-26 4:05 pm |
N/A N/A |
Cyclerion Therapeutics Inc. | CYCN | Graul Regina Margaret President |
50,000 | $0 | 100,303 (Direct) |
View |
Ownership |
2023-12-11 5:09 pm |
N/A N/A |
Cyclerion Therapeutics Inc. | CYCN | Katabi Dina Director |
0 | $0 | 20,000 (Direct) |
View |
Ownership |
2023-12-07 4:05 pm |
N/A N/A |
Cyclerion Therapeutics Inc. | CYCN | Higgins Michael J Director |
0 | $0 | 21,650 (Direct) |
View |
Ownership(A) |
2023-12-07 4:05 pm |
N/A N/A |
Cyclerion Therapeutics Inc. | CYCN | Graul Regina Margaret President |
0 | $0 | 50,303 (Direct) |
View |
Ownership |
2023-12-04 4:05 pm |
N/A N/A |
Cyclerion Therapeutics Inc. | CYCN | Graul Regina Margaret President |
0 | $0 | 50,000 (Direct) |
View |
| 2023-11-30 Option Award |
2023-12-04 4:05 pm |
N/A N/A |
Cyclerion Therapeutics Inc. | CYCN | MCGUIRE TERRANCE Director |
5,000 | $0 | 42,010 (Direct) |
View |
| 2023-11-30 Option Award |
2023-12-04 4:05 pm |
N/A N/A |
Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M Director 10% Owner |
35,000 | $0 | 362,457 (Direct) |
View |
| 2023-11-30 Option Award |
2023-12-04 4:05 pm |
N/A N/A |
Cyclerion Therapeutics Inc. | CYCN | DESOUZA ERROL B Director |
50,000 | $0 | 30,000 (Direct) |
View |
| 2023-11-30 Option Award |
2023-12-04 4:04 pm |
N/A N/A |
Cyclerion Therapeutics Inc. | CYCN | Hyman Steven Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-22 8:43 pm |
N/A N/A |
Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M Chief Executive Officer 10% Owner |
576,037 | $8.68 | 678,494 (Direct) |
View |
| 2022-07-25 Option Award(A) |
2022-07-27 4:40 pm |
N/A 2032-07-25 |
Cyclerion Therapeutics Inc. | CYCN | Hyman Steven Director |
57,753 | $0 | 57,753 (Direct) |
View |
| 2022-07-25 Option Award |
2022-07-26 4:33 pm |
N/A 2032-07-25 |
Cyclerion Therapeutics Inc. | CYCN | Hyman Steven Director |
57,753 | $0 | 57,753 (Direct) |
View |
Ownership |
2022-07-26 4:30 pm |
N/A N/A |
Cyclerion Therapeutics Inc. | CYCN | Hyman Steven Director |
0 | $0 | 0 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 8:56 pm |
N/A 2032-06-14 |
Cyclerion Therapeutics Inc. | CYCN | MCGUIRE TERRANCE Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 8:56 pm |
N/A 2032-06-14 |
Cyclerion Therapeutics Inc. | CYCN | Mendelsohn Michael Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 8:56 pm |
N/A 2032-06-14 |
Cyclerion Therapeutics Inc. | CYCN | Fanucci Marsha Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 8:56 pm |
N/A 2032-06-14 |
Cyclerion Therapeutics Inc. | CYCN | Lovell Stephanie Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 8:56 pm |
N/A 2032-06-14 |
Cyclerion Therapeutics Inc. | CYCN | CONRADES GEORGE H Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 8:55 pm |
N/A 2032-06-14 |
Cyclerion Therapeutics Inc. | CYCN | Isacson Ole Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 8:55 pm |
N/A 2032-06-14 |
Cyclerion Therapeutics Inc. | CYCN | DESOUZA ERROL B Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-24 11:48 am |
N/A 2032-01-20 |
Cyclerion Therapeutics Inc. | CYCN | Busch Andreas Chief Scientific Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-24 11:43 am |
N/A 2032-01-20 |
Cyclerion Therapeutics Inc. | CYCN | Gjino Anjeza Chief Financial Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-24 11:38 am |
N/A 2032-01-03 |
Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M Chief Executive Officer |
482,950 | $0 | 482,950 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-24 11:33 am |
N/A 2032-01-20 |
Cyclerion Therapeutics Inc. | CYCN | Gault Cheryl Chief Operating Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2021-12-09 Option Award |
2021-12-10 4:32 pm |
N/A 2031-12-09 |
Cyclerion Therapeutics Inc. | CYCN | Busch Andreas Chief Scientific Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2021-12-09 Option Award |
2021-12-10 4:31 pm |
N/A 2031-12-09 |
Cyclerion Therapeutics Inc. | CYCN | Gjino Anjeza Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-12-09 Option Award |
2021-12-10 4:31 pm |
N/A 2031-12-09 |
Cyclerion Therapeutics Inc. | CYCN | Gault Cheryl Chief Operating Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 5:27 pm |
N/A 2031-06-24 |
Cyclerion Therapeutics Inc. | CYCN | Lovell Stephanie Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 5:25 pm |
N/A 2031-06-24 |
Cyclerion Therapeutics Inc. | CYCN | Fanucci Marsha Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 5:22 pm |
N/A 2031-06-24 |
Cyclerion Therapeutics Inc. | CYCN | Isacson Ole Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 5:17 pm |
N/A 2031-06-24 |
Cyclerion Therapeutics Inc. | CYCN | Churchwell Kevin Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 5:14 pm |
N/A 2031-06-24 |
Cyclerion Therapeutics Inc. | CYCN | Mendelsohn Michael Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 5:11 pm |
N/A 2031-06-24 |
Cyclerion Therapeutics Inc. | CYCN | CONRADES GEORGE H Director |
10,000 | $0 | 10,000 (Direct) |
View |